Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Hospital has reported the first cases of Pediatric Multi-System Inflammatory Syndrome

Monday, May 11, 2020

New Haven, CT (May 11, 2020) – Yale New Haven Children’s Hospital (YNHCH) has reported Connecticut’s first cases of Pediatric Multi-System Inflammatory Syndrome. YNHCH currently has three patients diagnosed with the Syndrome believed to be tied to COVID-19. The Hospital has reported all three cases to the Connecticut Department of Public Health.

“Unfortunately, this disease carries features of toxic shock syndrome and elements of Kawasaki Disease and strikes school-aged children. While these cases are exceptionally rare, given our proximity to New York where there have been a significant number reported, we have been watching their experience closely,” said Clifford Bogue, physician-in-chief of YNHCH. “We are working diligently with local and state health officials to address this issue and strongly recommend that children who may be suffering from symptoms seek early referrals to pediatric infectious disease specialists, rheumatologists or cardiologists.”

Symptoms of Pediatric Multi-System Inflammatory Syndrome include a persistent fever, rash as well as gastrointestinal symptoms such as vomiting and diarrhea. Patients can also suffer from cardiac inflammation. If your child is experiencing any of these symptoms, please call your pediatrician for advice.

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.